Bipolar disorder is a severe mental illness characterised by recurrent depressive and manic episodes and associated with high levels of disability and premature mortality.[@ref1]^--^[@ref3] Although there are limited data from low- and middle-income countries (LMICs), the burden of bipolar disorder may be even higher in these settings because of the high treatment gap.[@ref1] As few as 10% of people with bipolar disorder receive care in some LMICs.[@ref4]^,^[@ref5] Even those who receive care may have limited access to evidence-based interventions, including mood stabilisers and psychosocial interventions.[@ref5]^,^[@ref6] In a cohort study of 312 community-ascertained people with bipolar disorder in Ethiopia, over 60% relapsed and only 5% remained continuously in remission over 2.5 years of follow-up,[@ref5] which appears much lower than what has been reported in high-income countries.[@ref7] Patients in low-income countries also appear to have substantially increased rates of mortality with nearly three decades of life lost because of premature death.[@ref2]

Mood stabilisers, such as lithium and sodium valproate, and atypical antipsychotics such as olanzapine, quetiapine and risperidone are the recommended evidence-based treatments for bipolar disorder.[@ref8] However, these medications are not widely available in many LMICs.[@ref4]^,^[@ref9] As a result, people with bipolar disorder in LMICs are often treated with first-generation antipsychotics during the maintenance phase.[@ref5]^,^[@ref6] First-generation antipsychotic medications are recommended in the latest version of the intervention guide of the Mental Health Gap Action Programme (mhGAP) in the absence of other options.[@ref10] However, they have extrapyramidal side-effects, especially when taken in high doses for an extended period of time[@ref11] and have poor evidence of efficacy as a maintenance treatment. Psychological treatments may play a crucial role in improving the outcome of bipolar disorder in LMICs where first-line treatments are not available for the majority of the population.

There is evidence from high-income countries that complementing pharmacotherapy with psychoeducation, family therapy or cognitive--behavioural therapy (CBT) for people with bipolar disorder is more effective at preventing relapse, improving medication adherence and overall disease outcome than pharmacotherapy alone.[@ref12]^--^[@ref14] The mhGAP intervention guideline recommends psychological intervention, especially psychoeducation to be delivered routinely for individuals with bipolar disorders.[@ref15] However, to date there has been no published synthesis of the evidence on the efficacy of adjunctive psychological interventions for bipolar disorder in LMIC settings. In this systematic review we aimed to synthesise the evidence base for the efficacy of adjunctive psychological interventions in improving clinical and functional outcomes in people with bipolar disorder in LMICs.

Method {#sec1}
======

Scope of review {#sec1-1}
---------------

We reviewed studies that aimed to examine the efficacy of any psychological intervention in improving clinical and functional outcomes, including prevention of relapse or recurrence and hospital admissions; treatment adherence, biological rhythms, quality of life (QoL) and knowledge and attitude about bipolar disorder among people with bipolar disorder.

Search strategies {#sec1-2}
-----------------

We searched Medline, PsycINFO, EMBASE, PubMed, Cochrane database for systematic review, Cochrane central register of controlled trials, Latin America and Caribbean Center on Health Science Literature and African Journal of Online databases since the inception of the respective databases until the second week of May 2017 with no language restriction. The following terms were used to identify psychological interventions: 'Psychosocial intervention' OR 'Psychological intervention' OR 'Psychosocial therapy' OR 'Cognitive behavioral therapy' OR 'Cognitive Therapy' OR 'Behavior Therapy' OR 'Family focused intervention' OR 'Family intervention' OR 'Family therapy' OR Psychoeducation OR 'Interpersonal and social rhythm therapy' OR 'Social rhythm therapy' OR 'Interpersonal therapy' OR 'Mindfulness based cognitive therapy' OR Psychotherapy OR 'Expressed emotion' OR 'Individual therapy' OR 'Group therapy'). The search terms used for bipolar disorder were: 'Bipolar disorder' OR 'Bipolar and related disorders' OR Bipolar OR Mania OR 'Major affective disorder'. We used the World Bank definition and list of countries to identify LMICs. The search terms for intervention, bipolar disorder and LMICs were combined with the Boolean term 'AND'.

Outcomes of interest {#sec1-3}
--------------------

The main measures of efficacy of psychological interventions included: number of relapses or recurrence, severity of mood symptoms, treatment adherence, QoL, functional status, number of hospital admissions, knowledge and attitudes about bipolar disorder, and stigma and biological rhythms. The review protocol was registered in the PROSPERO database (CRD42017054572).[@ref16]

Inclusion criteria {#sec1-4}
------------------

Eligible articles were assessed against the following inclusion criteria: age: all ages were included;diagnosis: bipolar disorder I or II in any phase of the illness (depressive/manic/mixed episode or in remission);study setting: conducted in a LMIC according to the World Bank classification at the time of the study;[@ref17]type of study: (i) randomised controlled studies (RCT), or (ii) controlled before-and-after study;comparison groups: usual care, waiting list control or an active adjunctive psychological intervention;type of intervention: any psychological intervention delivered either face to face (individual or group format) or online.

Data extraction {#sec1-5}
---------------

Studies were first screened based on of their titles and abstracts, with the full texts obtained for those fulfilling the inclusion criteria. Two researchers (M.D. and R.B.) screened and extracted data independently using a customised data extraction form, which was piloted before the main data extraction. Any discrepancies were reconciled through discussions. Excluded articles and reasons for exclusion were documented.

Quality assessment {#sec1-6}
------------------

The consolidated standards of reporting studies (CONSORT)[@ref18] and the Cochrane assessment of risk of bias[@ref19] were used to assess the quality of the studies. The CONSORT checklist has 25 items on the quality of reporting of each section of the study including funding sources. The Cochrane assessment of risk of bias measures selection bias, performance bias, detection bias, attrition bias and reporting bias. The quality of studies was assessed independently by two researchers (M.D. and R.B.) and any differences were reconciled by a third researcher (A.F.). Assessment of the quality of the included studies was not used to exclude studies, but, to inform interpretation of the findings.

Method of analysis {#sec1-7}
------------------

Key findings were summarised in the form of figures, tables and text. Although the original plan was to conduct a meta-analysis and generate summary effect sizes of interventions, this was not possible because of the heterogeneity of the included studies in terms of: type of intervention, number of intervention sessions, duration of follow-up, format of intervention delivery and qualifications of the individuals delivering the intervention.

Results {#sec2}
=======

A total of 7987 articles were identified from the primary search. Of these, 532 were duplicates and were excluded. An additional 7213 were excluded because they were not related to bipolar disorder or to psychological interventions during the title screen and a further 162 during the abstract screen. Of the 80 studies included in full-text review, 62 were excluded because they were not from LMICs or were not related to bipolar disorder. This resulted in a total of 18 intervention studies for final analysis ([Fig. 1](#fig01){ref-type="fig"}). Four types of psychological intervention were identified: psychoeducation, family psychoeducation, CBT and mindfulness-based cognitive therapy (MBCT) ([Table 1](#tab01){ref-type="table"}). Fig. 1PRISMA flow diagram of the study selection process.PSI, Psychological intervention; LMICs, low- and middle-income countries. Table 1Summary of studies, interventions and patient characteristics for included studiesAuthorsBaseline, *n* (intervention/control)Type of treatment intervention/controlMode of interventionSessions, *n*Duration of intervention (weeks)Duration of follow-up (months)Faria *et al* 2014 (Brazil)[@ref20]32/29PE/TAUIndividual66Pre--postHusain *et al* 2017 (Pakistan)[@ref37]18/16PE/TAUIndividual1212Pre--postEker & Harkin 2012 (Turkey)[@ref29]36/35PE/TAUGroup66Pre--postCuhadar *et al* 2014 (Turkey)[@ref27]32/31PE/TAUGroup77Pre--postRahmani *et al* 2016 (Iran)[@ref34]38/38PE/TAUGroup105Pre--postDogan *&* Sabanciogullari 2003 (Turkey)[@ref28]16/16PE/TAUIndividual333George *et al* 2013 (India)[@ref35]30/30PE/TAUGroup4163Kurdal *et al* 2014 (Turkey)[@ref26]40/40PE/TAUGroup21113Faridhosseini *et al* 2017 (Iran)[@ref30]13/13PE/TAUGroup846Cardoso *et al* 2014 (Brazil)[@ref21]32/29PE/TAUGroup666Bahredar *et al* 2014 (Iran)[@ref32]15/15/15PE/TAU/placeboGroup996de Barros *et al* 2013 (Brazil)[@ref22]32/23PE/placeboGroup161612Gumus *et al* 2015 (Turkey)[@ref25]41/41PE/TAUIndividual4412Javadpour *et al* 2013 (Iran)[@ref31]54/54PE/TAUIndividual8818Bordbar *et al* 2009 (Iran)[@ref33]29/30FPE/TAUGroup1112Costa *et al* 2012 (Brazil)[@ref23]27/14CBT/TAUGroup14146Gomes *et al* 2011 (Brazil)[@ref24]23/27CBT/TAUGroup182212Ives-Deliperi *et al* 2013 (South Africa)[@ref36]16/7/10MBCT/TAU/HCGroup88Pre--post[^1]

Included studies {#sec2-1}
----------------

All studies were conducted in upper-middle-income countries except two, which was conducted in middle-income countries. There was only one study from Africa (South Africa). All of the 18 studies were published between 2003 and 2017 and were conducted in six countries. Brazil,[@ref20]^--^[@ref24] Turkey[@ref25]^--^[@ref29] and Iran[@ref30]^--^[@ref34] each contributed five studies, and India,[@ref35] South Africa[@ref36] and Pakistan[@ref37] each contributing only one study. Fifteen studies examined psychoeducation (five individual, nine groups, and one family intervention); two studies were of group CBT; and one study was group MBCT. All studies were RCTs, and all but two studies compared adjunctive psychological interventions with treatment as usual. The nature of 'treatment as usual' or the type of medication, was not specified in all these studies. the two studies that used an intervention comparison group, had used an equal number of sessions of relaxation and informal conversation,[@ref22] or non-specific support.[@ref32] The total number of participants in each study ranged from 26[@ref30] to 59.[@ref33] Overall follow-up time after the end of intervention ranged from 0 to 18 months ([Table 1](#tab01){ref-type="table"}).

Intervention content and intervention provider {#sec2-2}
----------------------------------------------

Providers of the intervention were specified in 15 of the 18 studies and included mental health specialists or practitioners (BSc psychiatric nurses,[@ref25]^--^[@ref27] MSc psychiatric nurses,[@ref34] clinical psychologists,[@ref23]^,^[@ref32]^,^[@ref37] MSc research psychology students,[@ref21] undergraduate psychologists[@ref20] psychiatrists or psychiatric residents[@ref22]^,^[@ref31]^,^[@ref33]) and therapists or people with some form of clinical experience.[@ref24]^,^[@ref29]^,^[@ref35] Although the majority of the studies did not indicated how the interventions were developed or adapted, most of the studies described the core content of the interventions. The content in most of the interventions was educational: education about bipolar disorder, symptoms of mania, depression, mixed and hypomanic episodes, causes and prognosis of bipolar disorder, treatment adherence and side-effects of medication, early identification of symptoms of relapse, triggering factors, substance use and regular habits and management plans or prevention strategies.

### Participant recruitment and outcome measures {#sec2-2-1}

The study participants were aged at least 18 years in all of the studies. Most of the participants were in remission during recruitment to the study and were recruited from the out-patient setting of a teaching or university hospital or from a public hospital. Most were receiving pharmacotherapy and follow-up from psychiatrists. In the majority of studies the Young Mania Rating Scale was used to measure manic symptom severity either as a categorical scale with an average cut-off of nine[@ref22]^--^[@ref25]^,^[@ref30]^,^[@ref32]^,^[@ref34]^--^[@ref37] or as a continuous scale.[@ref20]^,^[@ref21] Similarly, in the majority of the studies, the Hamilton Rating Scale for Depression was used to measure depressive symptom severity either as a categorical scale with an average cut-off point of eight[@ref22]^,^[@ref24]^,^[@ref25]^,^[@ref30]^--^[@ref32]^,^[@ref34]^,^[@ref35] or as a continuous measure.[@ref20]^,^[@ref21] Five studies included people with bipolar I or II disorder, three studies recruited only individuals with bipolar I disorder and two studies recruited only those with bipolar II disorder; the remaining eight studies did not specify the type of bipolar disorder. In 16 studies, the DSM-IV was used as the diagnostic tool, with psychiatrist-confirmed diagnoses in 11 studies. Two studies did not describe who confirmed the diagnosis.[@ref27]^,^[@ref35] Details of other outcome measures are provided in supplementary file 1 available at <https://doi.org/10.1192/bjo.2018.46>.

Quality of included studies {#sec2-3}
---------------------------

The overall quality of reporting of the studies was not satisfactory as per the CONSORT checklist. Only three of the studies were registered in a registration database. Although all studies clearly reported the objective of the study. Only 55% of the studies reported how the sample size was determined. Sources of funding and the role of funders were reported in only two-thirds of the studies. The risk of bias assessed with the Cochrane assessment tool was moderately high. Although randomisation was carried out in all the studies, the method of randomisation was unclear in 40% of studies and allocation concealment was unclear in 80% of studies. Fifteen studies were rated as unclear and three studies had a high risk of detection bias. One-third of the studies were rated as having high attrition bias because of unequal numbers of people dropping out in the randomised groups or different reasons for drop-out or because of attrition greater than 10%. One-third of studies were rated as being at high risk of reporting bias because they did not report the mean and standard deviation of mood severity symptoms, between-group differences for selected outcomes, and number of participants who had a relapsed/recurrence (see supplementary files 2--4).

Efficacy of interventions {#sec2-4}
-------------------------

### Prevention of relapse/recurrence {#sec2-4-1}

Six studies (four psychoeducation, one family psychoeducation and one CBT) examined the impact of the psychological intervention on prevention of relapse or recurrence ([Table 2](#tab02){ref-type="table"}). Psychoeducation was effective in reducing the relapse rate,[@ref25]^,^[@ref30]^,^[@ref31]^,^[@ref33] as well as increasing mean time to first relapse.[@ref33] However, one study showed that psychoeducation was not effective in people who had multiple previous relapses.[@ref22] CBT was ineffective in decreasing the number of relapses but was effective in prolonging the median time to first relapse compared with treatment as usual.[@ref24] Table 2Psychological interventions for prevention of relapse/recurrenceAuthorsIntervention groupFinal analysis, *n* (intervention/ control)Outcome measuredProportion with outcome χ^2^*ZP*Intervention groupControl groupde Barros *et al* 2013 (Brazil)[@ref22]G-PE *v.* placebo28/18Depressive relapse----*----*0.18Manic relapse----*----*0.09Gomes *et al* 2011 (Brazil)[@ref24]G-CBT *v.* TAU22/25Relapse, *n*14/2314/270.280.590Time to first relapse, median (range) weeks31 (66)11.5 (48)−2.5540.011Gumus *et al* 2015 (Turkey)[@ref25]I-PE *v.* TAU37/41Recurrence, *n*7/3714/411.583--0.21Experienced more than one recurrence, *n*280.36--0.221Faridhosseini *et al* 2017 (Iran)[@ref30]G-PE *v.* TAU12/12Recurrence, *n*1/139/13*----*0.001Patients experienced more than one relapse, *n*02*----*Javadpour *et al* 2013 (Iran)[@ref31]I-PE *v.* TAU45/41Average number of recurrences0.772.02*----*\<0.001Bordbar *et al* 2009 (Iran)[@ref33]G-FPE *v.* TAU29/28Total relapse, *n*4/299/28*----*0.006Experienced more than one recurrence, *n*12*----*--Time to first relapse in months, mean64.8*----*--[^2]

### Reduction in symptom severity {#sec2-4-2}

Nine studies (seven psychoeducation, one CBT and one MBCT) assessed the efficacy of psychological intervention in reducing symptom severity. One study reported change in mood-only symptom severity within each of the randomised groups[@ref28] ([Table 3](#tab03){ref-type="table"}). Table 3Psychological intervention for reducing symptom severityAuthorsFinal analysis, *n* (intervention/control)InterventionAssessment time (month)Test statistics and *P*Measure of effectMood symptom severityDogan & Sabanciogullari (2003)[@ref28]14/12I-PE *v.* TAU3I-PE: *Z* = 2.41; *P* \< 0.01^a^--TAU: *Z* = 1.05; *P* \> 0.05^a^--Depressive symptoms Faria *et al* (2014)[@ref20]19/26I-PE *v.* TAUPost-intervention*P* = 0.40AMD = −1.86 (95% CI −6.34 to 2.61) Husain *et al* (2017)[@ref37]16/11I-PE *v.* TAU3*Z* = 3.21; *P* = 0.001AMD = −10.3 (95% CI −16.8 to −4.5), SES = −1.17 Javadpour *et al* (2013)[@ref31]45/41I-PE *v.* TAU18*P* \< 0.001-- Faridhosseini *et al* (2017)[@ref30]12/12G-PE *v.* TAUPost-intervention*P* = 0.58Mean 1.0 (s.e. = 1.78) Cardoso *et al* (2014)[@ref21]19/26G-PE *v.* TAUPost-intervention*F* = 0.66, *P* = 0.81--6*F* = 0.99, *P* = 0.324-- de Barros *et al* (2013)[@ref22]28/18G-PE *v.* placebo12*P* = 0.820ES = 0.007 Costa *et al* (2012)[@ref23]25/12G-CBT *v.* TAU6*P* \< 0.05-- Ives-Deliperi *et al* (2013)[@ref3][@ref6]16/7G-MBCT *v.* TAUPost-intervention*P* \> 0.05--Manic symptoms Faria *et al* 2014[@ref20]19/26I-PE *v.* TAUPost-intervention*P* = 0.06AMD = −5.93 (95% CI −0.28 to −12.15) Husain *et al* 2017[@ref37]16/11I-PE *v.* TAU3*Z* = 4.67, *P* \< 0.001AMD = −6.0 (95% CI −8.7 to 3.7), SES = −1.18 Javadpour *et al* 2013[@ref31]45/41I-PE *v.* TAU18*P* \< 0.001-- Faridhosseini *et al* 2017[@ref30]12/12G-PE *v.* TAUPost-intervention*P* = 0.04Mean 1.91 (s.e.) 0.88 Cardoso *et al* (2014)[@ref21]19/26G-PE *v.* TAUPost-intervention*F *= 2.16, *P* = 0.15--6*F *= 2.94, *P* = 0.09-- de Barros *et al* (2012)[@ref22]28/18G-PE *v.* placebo12*P* = 0.72ES = 0.02 Costa *et al* (2012)[@ref23]25/12G-CBT *v.* TAU6*P* \> 0.05--Anxiety symptoms Ives-Deliperi *et al* (2013)[@ref36]16/7G-MBCT *v.* TAUPost-intervention*t* = 2.3, *P* = 0.05-- Costa *et al* (2012)[@ref23]25/12G-CBT *v.* TAU6*P* = 0.02*R*^2^ = 0.9Emotional dysregulation Ives-Deliperi *et al* (2013)[@ref36]16/7G-MBCT *v.* TAUPost-intervention*t* = 4.1, *P* = 0.01--[^3][^4]

Studies reported significant reduction in general psychiatric symptom severity,[@ref28] depressive symptom severity[@ref21]^,^[@ref31]^,^[@ref37] and manic symptom severity,[@ref20]^,^[@ref21]^,^[@ref30]^,^[@ref31]^,^[@ref37] immediately post-intervention and during follow-up. However, in one study where 60% of total participants had more than ten previous bipolar episodes, there was worsening of depressive symptoms in both groups and there was significant change and between-group difference in manic symptoms.[@ref22] CBT was effective in reducing depressive and anxiety symptoms compared with treatment as usual.[@ref23] MBCT was associated with significant improvement in anxiety symptoms, emotional dysregulation and mindfulness, but did not reduce depressive symptoms among intervention groups compared with the patients with bipolar disorder on the waiting list.[@ref36]

### Improvement in biological rhythms {#sec2-4-3}

Only one study[@ref20] from Brazil assessed the efficacy of six sessions of complementary psychoeducation in improving biological rhythms (sleep, activity, patterns of habitual daily behaviour (social rhythm) and eating pattern) among patients with bipolar disorder, 80% of whom had more than six previous bipolar episodes. The study reported significant improvement in the control rather than the intervention group (adjusted mean difference  −10.84, 95% CI −20.6 to −1.07, *P* = 0.03).[@ref20]

### Improvement in knowledge, attitude and internalised stigma {#sec2-4-4}

Four psychoeducation studies were identified.[@ref27]^,^[@ref28]^,^[@ref35]^,^[@ref37] Three of the four studies assessed the efficacy of psychoeducation in improving knowledge and attitudes about bipolar disorder, and one trial assessed the efficacy of psychoeducation in reducing internalised stigma. Two of the four studies reported within-group difference by comparing post-intervention against baseline scores in each group.[@ref27]^,^[@ref28] Generally, the findings showed a positive effect of psychoeducation in improving knowledge and attitudes about bipolar disorder and internalised stigma (see supplementary file 5).

### Improvement in treatment adherence {#sec2-4-5}

A total of nine studies, eight psychoeducation and one family-focused intervention, reported short- and long-term improvements in treatment adherence compared with treatment as usual[@ref28]^--^[@ref35]^,^[@ref37] ([Table 4](#tab04){ref-type="table"}). Table 4Psychological intervention to improve adherenceAuthorsFinal analysis, *n* (intervention/control)MeasurementFollow-up duration after post-intervention (months)GroupAssessment time point, mean (s.d.)/mean/%Test statistics, *P*Measure of effectBaseline assessmentEnd-line assessmentAdherence to medicationsHusain *et al* 2017 (Pakistan)[@ref37]16/11MMAS--I-PE1.7 (1.7)0.9  (1.4)*Z* = 2.37, *P* = 0.018AMD = −1.22 (95% CI −2.18 to 0.14), SES = 0.81TAU1.3 (1.7)2.1  (1.5)Rahmani *et al* 2016 (Iran)[@ref34]36/36MARS--G-PE6.8  (1.9)9.4  (2.4)*t* = 0.29, *P* \< 0.001AMD = 2.3 (95% CI 2.21 to 2.14)TAU6.6 (1.4)7.1  (2.2)Total score, MAC--PE10.6 (2.5)17.8  (3.7)*t* = 0.35, *P* \< 0.001AMD = 7.7 (95% CI 7.20 to 9.50)TAU9.8  (2.2)10.1 (2.3)Javadpour *et al* 2013 (Iran)[@ref31]45/41MARS18I-PE--7.91*P* = 0.008--TAU--3.73Bahredar *et al* 2014 (Iran)[@ref32]15/15/15MARS6G-PE6.27  (0.88)7.92 (1.38)*F*(2,31) = 55.1, *P* \< 0.001--TAU6.53 (0.64)4.33 (0.49)Placebo6.47 (0.52)4.36 (0.67)Bordbar *et al* 2009 (Iran)[@ref33]29/28Duration of continuing medication in month3G-FPE--2.46  (0.46)*t* = 1.23, *P* = 0.227--TAU--2.67 (0.48)6G-FPE--5.76 (0.51)*t* = 4.36, *P* \< 0.001--TAU--5.00  (0.77)9G-FPE--8.48 (0.95)*t* = 4.88, *P* \< 0.001--TAU--7.04 (1.26)12G-FPE--11.41 (1.02)*t* = 6.88, *P* \< 0.001--TAU--9.14  (1.43)Dogan & Sabanciogullari 2003 (Turkey)[@ref28]14/12Proportion of patients who use lithium regularly--I-PE35.7%85.7%*P* = 0.008--TAU50%41.7%Proportion of patients with normal serum lithium level--I-PE57.1%100%*P* = 0.016--TAU58.3%58.3%Eker & Harkin 2012 (Turkey)[@ref29]30/33MARS--G-PE40%86.7%χ^2^ = 24.649, *P* \< 0.01--TAU38.9%24.2%George *et al* 2013 (India)[@ref35]24/26Patient\'s diary and counting tablets3G-PE--100%*P* = 0.111--TAU--84.6%Adherence to psychiatric visit Bordbar *et al* 2009 (Iran)[@ref33]29/28Number of psychiatric visit3G-FPE--2.76 (0.43)*t* = 1.38, *P* \< 0.017--TAU--2.57 (0.57)6G-FPE--5.34  (0.81)*t* = 3.72, *P* \< 0.001----TAU--4.46 (0.96)9G-FPE--7.72 (1.36)*t* = 3.98, *P* \< 0.001----TAU--6.21 (1.50)12G-FPE--10.34 (1.54)*t* = 5.52, *P* \< 0.001----TAU--7.86  (1.84) Faridhosseini *et al* 2017 (Iran)[@ref30]12/12Patient and family report6G-PE--3.25 (0.69)*P* = 0.02--TAU--1.41 (1.67)[^5]

### Reduction in hospital admissions {#sec2-4-6}

A total of five RCTs that assessed the efficacy of individual, group or family psychoeducation in reducing hospital admissions were identified (see supplementary file 6). Generally, the studies showed that fewer people with bipolar disorder were admitted to hospital in the intervention group compared with the control group.[@ref25]^,^[@ref30]^,^[@ref31]^,^[@ref33]

### Improvement in QoL and functional status {#sec2-4-7}

A total of 10 of the 18 studies (9 psychoeducation and 1 CBT) assessed the efficacy of improving functional status and QoL ([Table 5](#tab05){ref-type="table"}). The findings were mixed. Half of the studies reported, significant improvement in various domains of QoL in the intervention compared with the control groups: functioning,[@ref26]^,^[@ref28]^,^[@ref32] general health,[@ref28] physical, social,[@ref28]^,^[@ref31] environmental and mental health domains of QoL[@ref31] and in the overall QoL.[@ref37] In one study, there was significant improvement in all domains of QoL except the mental health domain in those receiving CBT compared with treatment as usual.[@ref23] The rest of the studies did not reported significant differences between groups.[@ref21]^,^[@ref22]^,^[@ref27]^,^[@ref30] Table 5Psychological intervention to improve quality of life and functioningReferenceFinal analysis, *n* (intervention/control)InterventionFollow-up duration after post-intervention (month)OutcomeTest statistics and *P*Measure of effectHusain *et al* 2017 (Pakistan)[@ref37]16/11I-PE *v.* TAU3Overall QoL in EQ-5D index*Z* = 2.47, *P* = 0.01AMD = 0.24 (95% CI 0.1--0.5), SES = 0.88Overall QoL in EQ-5D VAS*Z* = 3.65, *P* \< 0.001AMD = 26.8 (95% CI 12.2--41.8), SES = 1.14Dogan & Sabanciogullari 2003 (Turkey)[@ref28]14/12I-PE *v.* TAU3General health domain*Z* = 2.56, *P* \< 0.01^a^Physical aspect*Z* = 2.67, *P* \< 0.01^a^Psychological*Z* = 1.58, *P* \> 0.05^a^Social aspects*Z* = 2.10, *P* \< 0.05^a^Environmental*Z* = 1.38, *P* \> 0.05^a^Javadpour *et al* 2013 (Iran)[@ref31]45/41I-PE *v.* TAU18Physical aspect*P* \< 0.001Mental health*P* \< 0.001Social aspects*P* \< 0.001Environmental*P* \< 0.001Faridhosseini *et al* 2017 (Iran)[@ref30]12/12G-PE *v.* TAU−Overall QoL*P* = 0.196Mean 3.12 (s.d. = 2.34)Cuhadar *et al* 2014 (Turkey)[@ref2][@ref7]24/23G-PE *v.* TAU--Emotional functioning*Z *= −0.21, *P* = 0.08^a^Mental functioning*Z* = −1.93, *P* = 0.05^a^Sexual functioning*Z* = −0.34, *P* = 0.73^a^Feelings of stigmatisation*Z* = −0.95, *P* = 0.34^a^Introversion*Z* = −1.50, *P* = 0.13^a^Domestic relationships*Z* = −2.18, *P* = 0.03^a^Relations with friends*Z *= −1.59, *P* = 0.11^a^Participating in social activities*Z* = −1.80, *P* = 0.07^a^Daily and recreational activities*Z* = −0.15; *P* = 0.88^a^Taking initiative and using one\'s potential*Z* = −0.00, *P* = 1.00^a^Work*Z* = −0.54, *P* = 0.59^a^Kurdal *et al* 2014 (Turkey)[@ref26]40/40G-PE *v.* TAU3Emotional functioning*t* = 4.04, *P* \< 0.001Intellectual functioning*t* = 7.46, *P* \< 0.001Sexual functioning*t* = 1.87, *P* \> 0.050Feelings of stigmatisation*t* = 7.84, *P* \< 0.001Social withdrawal*t* = 7.00, *P* \< 0.001Household relations*t* = 7.84, *P* \< 0.001Relations with friends*t* = 3.46, *P* \< 0.001Participating in social activities*t* = 3.66, *P* \< 0.001Daily and recreational activities*t* = 3.11, *P* \< 0.005Taking initiative and self-sufficiency*t* = 3.61, *P* \< 0.001Occupation*t* = 2.01, *P* \< 0.050Bahredar *et al* 2014 (Iran)^32^15/15/15G-PE *v.* placebo and TAU6GAF score*F*(2,31) = 90.93, *P* \< 0.001Cardoso 2014 (Brazil)[@ref21]19/26G-PE *v.* TAU6Functional capacity*F* = 0.08, *P* = 0.78Pain*F *= 1.98, *P* = 0.17General health status*F* = 0.04, *P* = 0.84Vitality*F* = 0.39, *P* = 0.54Social aspects*F* = 0.62, *P* = 0.44Emotional aspects*F* = 0.24, *P* = 0.63Mental health*F* = 1.19, *P* = 0.28de Barros *et al* 2012 (Brazil)[@ref22]28/18G-PE *v.* placebo12Social domain*P* = 0.42ES = 0.42Environmental domain*P* = 0.82Functioning*P* = 0.59ES = 0.03Clinical improvement patient view*P* = 0.02ES = 0.35Clinical improvement clinician view*P* = 0.57ES = 0.04Costa *et al* 2012 (Brazil)[@ref23]25/12G-CBT *v.* TAU6Functional capacity*P* = 0.007*R*^2^ = 0.65Pain*P* = 0.020*R*^2^ = 0.60General health status*P* = 0.002*R*^2^ = 0.77Vitality*P* = 0.036*R*^2^ = 0.46Social aspects*P* = 0.044*R^2^ *= 0.41Emotional aspects*P* = 0.001*R*^2^ = 0.56Mental health*P* = 0.081*R*^2^ = 0.46[^6][^7]

Discussion {#sec3}
==========

This is the first systematic review synthesising the full range of psychological intervention studies that have been conducted among people with bipolar disorder in LMICs. In all studies reviewed, psychological interventions were given as adjuncts to treatment as usual, although the treatment as usual may have varied depending on drug licensing and treatment guidelines in each country. Nearly all of the included studies were conducted in upper-middle-income countries and none of the studies were from low-income countries compromising ability for direct generalisation of findings to low-income country settings. Absence of such studies in low-income countries may be linked to the broader lack of attention to bipolar disorder globally as well as in LMICs. The scarcity of clinician researchers[@ref38] coupled with the poor funding environment may explain the scarcity of data on psychopathology, incidence, prevalence and course of bipolar disorder in LMICs.[@ref39] However, even if focusing on upper-middle-income countries, these studies are important bridges to the broader LMIC setting than studies conducted in high-income countries. Additionally, the core principles of treatment were shared among the studies. For example, psychoeducation included in all the studies, is naturally consistent across settings. Most of the studies were tested in teaching or public hospitals with no intervention adaptations to the local context, which adds to the challenge of transferring these interventions. Nonetheless, identifying interventions of proven efficacy that have at least been tested outside of a high-income setting is a good starting point for adapting psychological intervention for LMICs. Therefore, they can be considered as potential candidates for further adaptation. Such an approach was taken when adapting psychological interventions for perinatal common mental disorders in LMICs with some success.[@ref40] In general, the findings suggest the need for rigorous studies in LMICs.

Overall, the reviewed studies demonstrate the efficacy of adjunctive psychological interventions for bipolar disorder in terms of improving both depressive and manic symptoms, reducing relapse, hospital admissions and internalised stigma, improving QoL, treatment adherence and knowledge and attitudes about bipolar disorder

The majority of the studies assessed the efficacy of psychoeducation and all studies included a psychoeducation component. This is in line with the World Health Organization mhGAP intervention guideline, which endorses routine psychoeducation for people with bipolar disorders.[@ref15] However, the mhGAP does not provide guidance on the number of sessions, content and delivery of the psychoeducation. In this review, 3 to 12 sessions of group, individual and family psychoeducation were effective in reducing relapse, hospital admissions and illness severity for both depression and mania. Therefore, a minimum of three sessions of psychoeducation may be required although a lower number of sessions may have to be tested. Furthermore, the mhGAP guideline is designed to be used by general health workers. However, in this review, most psychological interventions were delivered by mental health specialists and there was no evidence in relation to task-sharing with general health workers. This implies that there is no evidence to support psychoeducation provided by general health workers and calls for further evidence on this from LMICs.

It was also of interest to note that just one session of family psychoeducation improved outcomes on multiple domains: treatment adherence, relapse rates and hospital admissions.[@ref33] Given the family orientation of care in LMICs, brief family psychoeducation is a promising intervention that could be tested in the general healthcare context. Although this review confirms the benefits of psychological interventions as reported in high-income countries,[@ref41]^,^[@ref42] caution may be required in patients with a long duration of illness and multiple relapses. One of the reports where most of the participants had experienced multiple relapses and a long duration of illness (an average of 19 years), depressive symptoms worsened in both the treatment and control groups.[@ref22] This may indicate that psychological interventions may be more effective for people with bipolar disorder who have experienced fewer relapses and have a short disease duration.[@ref12]^,^[@ref42] Findings related to CBT were consistent with those from high-income countries.[@ref41]^,^[@ref42]

Limitations {#sec3-1}
-----------

The review was comprehensive in terms of databases searched and types of psychological interventions and study designs. However, a meta-analysis was not possible because of the heterogeneity of the included studies in terms of the type of interventions, number of sessions and duration of follow-up time and format of intervention delivery. Second, studies with negative findings might not have been published. Additionally, two of the papers[@ref27]^,^[@ref28] carried out within-group comparisons with post-assessment against baseline. Non-availability of the raw data precluded re-analysis. Third, since nearly all the studies were from upper-middle-income countries, the findings may not be directly generalisable to low-income country settings (see supplementary file 7 for a list of countries by income group).

Implications {#sec4}
============

The reviewed literature showed promising results relating to the efficacy of adjunctive psychological interventions on a broad range of clinical and QoL parameters in LMICs. However, virtually all studies identified in this comprehensive review were from upper-middle-income countries and none involved general health workers. Contextually appropriate adaptation of interventions for low-income settings and for task-shifted care as well as larger-scale studies are important next steps.
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[^1]: PE, psychoeducation; TAU, treatment as usual; FPE, family psychoeducation; CBT, cognitive--behavioural therapy; MBCT, mindfulness-based cognitive therapy; HC, Healthy control.

[^2]: G-PE, group psychoeducation; G-CBT, group cognitive--behavioural therapy; TAU, treatment as usual; I-PE, individual psychoeducation; G-FPE, group family psychoeducation.

[^3]: I-PE, individual psychoeducation; TAU, treatment as usual; AMD, adjusted mean difference; SES, standardised effect size; G-PE, group psychoeducation; ES, effect size; G-CBT, group cognitive--behavioural therapy; G-MBCT, group mindfulness-based cognitive therapy; *R*^2^, squared value of correlation coefficient or the proportion of explained variation.

[^4]: a\. The comparison was made within arm and the reported result for the treatment group.

[^5]: MMAS, Morisky Medication Adherence Scale; I-PE, individual psychoeducation; TAU, treatment as usual; AMD, adjusted mean difference; SES, standardised effect size; MARS, Medication Adherence Rating Scale; G-PE, group psychoeducation; MAC, Medicine Adherence Checklist; PE, psychoeducation; G-FPE, group family psychoeducation.

[^6]: I-PE, individual psychoeducation; TAU, treatment as usual; AMD, adjusted mean difference; SES, standardised effect size; VAS, visual analogue scale; G-PE, group psychoeducation; QoL, quality of life; GAF, Global Assessment of Functioning; ES, effect size; G-CBT, group cognitive--behavioural therapy; *R*^2^, squared value of correlation coefficient or the proportion of explained variation.

[^7]: a\. The comparison was made within arm and the reported result for the treatment group.
